GlassScriptPhysician profile
Kristin E Harper
NPI 1336631548
$4,116.65
in general payments reported to CMS, 2019-2025
27 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $114 · 2021: $344 · 2022: $2,715 · 2023: $456 · 2024: $172 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $2,529.40 | 2022-2024 | |
| Smith+Nephew, INC. | $263.27 | 2020-2025 | Grafix Pl, Renasys Touch, Stravix |
| Medical Device Business Services, INC. | $199.99 | 2021 | |
| Nevro Corp. | $179.95 | 2022-2023 | Senza |
| Heron Therapeutics, INC. | $123.39 | 2023 | Zynrelef |
| Organogenesis INC. | $104.39 | 2024-2025 | Cygnus Dual, Nushield, Puraply Wound Matrix |
| Stryker Corporation | $87.24 | 2022 | |
| Orthofix Medical, INC. | $75.71 | 2021 | |
| Abbott Laboratories | $63.58 | 2023-2025 | Axium, Proclaim |
| Stability Biologics, LLC | $48.87 | 2021 | |
| Integra Lifesciences Corporation | $47.31 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $45.85 | 2022-2023 | Nuzyra |
| Tactile Systems Technology INC | $39.29 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Vertex Pharmaceuticals Incorporated | $36.14 | 2025 | |
| Bioventus LLC | $33.61 | 2023-2025 | Exogen Ultrasound Bone Healing System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $32.80 | 2023-2024 | |
| Amgen INC. | $30.12 | 2024-2025 | Krystexxa |
| Paragon 28, INC. | $24.03 | 2025 | Precision Mis Bunion |
| Janssen Pharmaceuticals, INC | $19.69 | 2021 | |
| Treace Medical Concepts, INC. | $19.23 | 2025 | |
| Globus Medical, INC. | $18.45 | 2025 | Senza |
| Depuy Synthes Sales INC. | $18.45 | 2025 | |
| Hartmann USA, INC. | $17.82 | 2023 | Zetuvit Plus |
| Highridge Medical LLC | $17.63 | 2024 | Biomet Ebi Bone Healing System |
| Cumberland Pharmaceuticals, INC. | $16.63 | 2024 | Caldolor |
| Nabriva Therapeutics, Plc | $14.31 | 2022 | |
| Kerecis Limited | $9.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.